Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Acquisitions (2022)

iBio (IBIO) has disclosed Acquisitions for 1 consecutive years, with $692000.0 as the latest value for Q3 2022.

  • On a quarterly basis, Acquisitions changed N/A to $692000.0 in Q3 2022 year-over-year; TTM through Jun 2023 was $692000.0, a N/A change, with the full-year FY2023 number at $692000.0, changed N/A from a year prior.
  • Acquisitions was $692000.0 for Q3 2022 at iBio.
  • In the past five years, Acquisitions ranged from a high of $692000.0 in Q3 2022 to a low of $692000.0 in Q3 2022.